Melinta Therapeutics Completes Acquisition of The Medicines Company’s Infectious Disease Portfolio
Jan 08, 2018 12:01 pm UTC| Business
— Expands portfolio to four marketed antibiotics, with peak sales potential over $1 billion —— Creates premier commercial stage global antibiotic franchise with the addition of Vabomere™(meropenem and vaborbactam),...
MiOS Announces Partnership with DSP Group Offering a Cloud Solution for IoT Applications
Jan 08, 2018 12:01 pm UTC| Business
SAN JOSE, Calif., Jan. 08, 2018 -- MiOS, the leading smart home services platform, announces its partnership with DSP Group, a leading global provider of wireless chipset solutions for converged communications. As part...
Merus and Simcere Announce Strategic Collaboration on Multiple Bispecific Antibodies
Jan 08, 2018 12:01 pm UTC| Business
UTRECHT, Netherlands and NANJING, China, Jan. 08, 2018 -- Merus (Nasdaq:MRUS) and Simcere Pharmaceutical Group today announced that Merus has agreed to grant Simcere an exclusive license to develop and commercialize in...
Akoustis® Readies For 5G By Completing Capital Buildout of Its First BAW RF Filter Line
Jan 08, 2018 12:01 pm UTC| Business
Charlotte, N.C., Jan. 08, 2018 -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented single-crystal BulkONE® bulk acoustic wave (BAW) high-band RF filters for mobile and...
Costas To Sell New Tech Crypto Kiosks Worldwide Starting Today
Jan 08, 2018 12:01 pm UTC| Business
LAS VEGAS, Jan. 08, 2018 -- via OTC PR WIRE -- Costas, Inc. (OTC:CSSI) wholly owned subsidiary, AuthentaCash, a division of AuthentaTrade Ltd. is now operational selling Cryptocoin Automated Teller Machines, referred to...
Reign Sapphire Corp. Provides Shareholder Update
Jan 08, 2018 12:01 pm UTC| Business
Los Angeles, CA, Jan. 08, 2018 -- Reign Sapphire Corp. (OTCQB: RGNP) ("Reign" or the "Company"), a direct-to-consumer, custom and branded jewelry company, is pleased to provide a shareholder update discussing highlights...
Emerald Health Therapeutics Appoints Paul R. Dillman, Jr. to Vice President of Sales and Marketing
Jan 08, 2018 12:01 pm UTC| Business
VICTORIA, British Columbia, Jan. 08, 2018 -- Emerald Health Therapeutics Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) today announced the appointment of Paul R. Dillman, Jr., as the Company's Vice President of Sales and...